Knows about the use of disease modifying anti-rheumatic drugs (DMARDs) in RA
Level
This learning outcome is a secondary level outcome.
This primary outcome(s) associated with this is (are):
Sessions
This learning outcome is taught in the following sessions:
Assessment
This learning outcome is assessed in the following ways:
- MBBS Pt 3 (Yr 3)
